Cell Replacement Therapy for Type 1 Diabetes Patients: Potential Mechanisms Leading to Stem-Cell-Derived Pancreatic β-Cell Loss upon Transplant
Abstract
:1. Introduction
2. Current and Potential Cell Replacement Strategies for T1D Patients
Islet Transplantation to Restore β-Cell Mass
3. Alternative Approaches to Increase Functional β-Cell Mass
4. Stem-Cell-Derived β-Cells as an Abundant Cell Source
5. Engrafted β-Cell Loss via Cell Death
6. De-Differentiation upon Transplantation: Do β-Cells Revert to Progenitor/Precursor Cells?
7. Transdifferentiation upon Transplantation: Do β-Cells Convert into Other Hormone-Expressing Cells?
8. β-Cell Subtype Interconversion upon Transplant
9. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Ionescu-Tirgoviste, C.; Gagniuc, P.A.; Gubceac, E.; Mardare, L.; Popescu, I.; Dima, S.; Militaru, M. A 3D map of the islet routes throughout the healthy human pancreas. Sci. Rep. 2015, 5, 14634. [Google Scholar] [CrossRef] [Green Version]
- Khan, M.A.B.; Hashim, M.J.; King, J.K.; Govender, R.D.; Mustafa, H.; Al Kaabi, J. Epidemiology of Type 2 Diabetes—Global Burden of Disease and Forecasted Trends. J. Epidemiol. Glob. Health 2020, 10, 107–111. [Google Scholar] [CrossRef] [Green Version]
- Patterson, C.; Guariguata, L.; Dahlquist, G.; Soltesz, G.; Ogle, G.; Silink, M. Diabetes in the young—A global view and worldwide estimates of numbers of children with type 1 diabetes. Diabetes Res. Clin. Pract. 2014, 103, 161–175. [Google Scholar] [CrossRef] [Green Version]
- Patrick, A.W.; Williams, G. Adverse effects of exogenous insulin. Clinical features, management and prevention. Drug Saf. 1993, 8, 427–444. [Google Scholar] [CrossRef]
- Carlson, M.G.; Campbell, P.J. Intensive insulin therapy and weight gain in IDDM. Diabetes 1993, 42, 1700–1707. [Google Scholar] [CrossRef]
- Sjølie, A.K. Ocular complications in insulin treated diabetes mellitus. An epidemiological study. Acta Ophthalmol. Suppl. 1985, 172, 1–77. [Google Scholar]
- Ryan, E.A.; Lakey, J.R.; Rajotte, R.V.; Korbutt, G.S.; Kin, T.; Imes, S.; Rabinovitch, A.; Elliott, J.F.; Bigam, D.; Kneteman, N.M.; et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 2001, 50, 710–719. [Google Scholar] [CrossRef] [Green Version]
- Shapiro, A.M.; Lakey, J.R.; Ryan, E.A.; Korbutt, G.S.; Toth, E.; Warnock, G.L.; Kneteman, N.M.; Rajotte, R.V. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 2000, 343, 230–238. [Google Scholar] [CrossRef]
- Shapiro, A.M.; Ricordi, C.; Hering, B.J.; Auchincloss, H.; Lindblad, R.; Robertson, R.P.; Secchi, A.; Brendel, M.D.; Berney, T.; Brennan, D.C.; et al. International trial of the Edmonton protocol for islet transplantation. N. Engl. J. Med. 2006, 355, 1318–1330. [Google Scholar] [CrossRef] [Green Version]
- Markmann, J.F.; Rickels, M.R.; Eggerman, T.L.; Bridges, N.D.; Lafontant, D.E.; Qidwai, J.; Foster, E.; Clarke, W.R.; Kamoun, M.; Alejandro, R.; et al. Phase 3 trial of human islet-after-kidney transplantation in type 1 diabetes. Am. J. Transplant. 2021, 21, 1477–1492. [Google Scholar] [CrossRef]
- Niclauss, N.; Bosco, D.; Morel, P.; Demuylder-Mischler, S.; Brault, C.; Milliat-Guittard, L.; Colin, C.; Parnaud, G.; Muller, Y.D.; Giovannoni, L.; et al. Influence of donor age on islet isolation and transplantation outcome. Transplantation 2011, 91, 360–366. [Google Scholar] [CrossRef]
- Rangel, E.B. Tacrolimus in pancreas transplant: A focus on toxicity, diabetogenic effect and drug-drug interactions. Expert Opin. Drug Metab. Toxicol. 2014, 10, 1585–1605. [Google Scholar] [CrossRef]
- Barton, F.B.; Rickels, M.R.; Alejandro, R.; Hering, B.J.; Wease, S.; Naziruddin, B.; Oberholzer, J.; Odorico, J.S.; Garfinkel, M.R.; Levy, M.; et al. Improvement in outcomes of clinical islet transplantation: 1999–2010. Diabetes Care 2012, 35, 1436–1445. [Google Scholar] [CrossRef] [Green Version]
- Goto, M.; Tjernberg, J.; Dufrane, D.; Elgue, G.; Brandhorst, D.; Ekdahl, K.N.; Brandhorst, H.; Wennberg, L.; Kurokawa, Y.; Satomi, S.; et al. Dissecting the instant blood-mediated inflammatory reaction in islet xenotransplantation. Xenotransplantation 2008, 15, 225–234. [Google Scholar] [CrossRef] [Green Version]
- Johansson, H.; Lukinius, A.; Moberg, L.; Lundgren, T.; Berne, C.; Foss, A.; Felldin, M.; Källen, R.; Salmela, K.; Tibell, A.; et al. Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes 2005, 54, 1755–1762. [Google Scholar] [CrossRef] [Green Version]
- Nilsson, B. The instant blood-mediated inflammatory reaction in xenogeneic islet transplantation. Xenotransplantation 2008, 15, 96–98. [Google Scholar] [CrossRef]
- Gill, R.G.; Wolf, L.; Daniel, D.; Coulombe, M. CD4+ T cells are both necessary and sufficient for islet xenograft rejection. Transplant. Proc. 1994, 26, 1203. [Google Scholar]
- Olack, B.J.; Jaramillo, A.; Benshoff, N.D.; Kaleem, Z.; Swanson, C.J.; Lowell, J.A.; Mohanakumar, T. Rejection of porcine islet xenografts mediated by CD4+ T cells activated through the indirect antigen recognition pathway. Xenotransplantation 2002, 9, 393–401. [Google Scholar] [CrossRef]
- Koulmanda, M.; Laufer, T.M.; Auchincloss, H.; Smith, R.N. Prolonged survival of fetal pig islet xenografts in mice lacking the capacity for an indirect response. Xenotransplantation 2004, 11, 525–530. [Google Scholar] [CrossRef]
- Kirchhof, N.; Shibata, S.; Wijkstrom, M.; Kulick, D.M.; Salerno, C.T.; Clemmings, S.M.; Heremans, Y.; Galili, U.; Sutherland, D.E.; Dalmasso, A.P.; et al. Reversal of diabetes in non-immunosuppressed rhesus macaques by intraportal porcine islet xenografts precedes acute cellular rejection. Xenotransplantation 2004, 11, 396–407. [Google Scholar] [CrossRef]
- Lindeborg, E.; Kumagai-Braesch, M.; Möller, E. Phenotypic and functional characterization of human T cell clones indirectly activated against adult pig islet cells. Xenotransplantation 2006, 13, 41–52. [Google Scholar] [CrossRef]
- Aghazadeh, Y.; Nostro, M.C. Cell Therapy for Type 1 Diabetes: Current and Future Strategies. Curr. Diab. Rep. 2017, 17, 37. [Google Scholar] [CrossRef]
- Sakata, N.; Sumi, S.; Yoshimatsu, G.; Goto, M.; Egawa, S.; Unno, M. Encapsulated islets transplantation: Past, present and future. World J. Gastrointest. Pathophysiol. 2012, 3, 19–26. [Google Scholar] [CrossRef]
- Matsumoto, S.; Tan, P.; Baker, J.; Durbin, K.; Tomiya, M.; Azuma, K.; Doi, M.; Elliott, R.B. Clinical porcine islet xenotransplantation under comprehensive regulation. Transplant. Proc. 2014, 46, 1992–1995. [Google Scholar] [CrossRef]
- Matsumoto, S.; Abalovich, A.; Wechsler, C.; Wynyard, S.; Elliott, R.B. Clinical Benefit of Islet Xenotransplantation for the Treatment of Type 1 Diabetes. EBioMedicine 2016, 12, 255–262. [Google Scholar] [CrossRef] [Green Version]
- Morozov, V.A.; Wynyard, S.; Matsumoto, S.; Abalovich, A.; Denner, J.; Elliott, R. No PERV transmission during a clinical trial of pig islet cell transplantation. Virus Res. 2017, 227, 34–40. [Google Scholar] [CrossRef]
- Rachdi, L.; Kariyawasam, D.; Aïello, V.; Herault, Y.; Janel, N.; Delabar, J.M.; Polak, M.; Scharfmann, R. Dyrk1A induces pancreatic β cell mass expansion and improves glucose tolerance. Cell Cycle 2014, 13, 2221–2229. [Google Scholar] [CrossRef] [Green Version]
- Wang, P.; Alvarez-Perez, J.C.; Felsenfeld, D.P.; Liu, H.; Sivendran, S.; Bender, A.; Kumar, A.; Sanchez, R.; Scott, D.K.; Garcia-Ocaña, A.; et al. A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication. Nat. Med. 2015, 21, 383–388. [Google Scholar] [CrossRef] [Green Version]
- Dirice, E.; Walpita, D.; Vetere, A.; Meier, B.C.; Kahraman, S.; Hu, J.; Dančík, V.; Burns, S.M.; Gilbert, T.J.; Olson, D.E.; et al. Inhibition of DYRK1A Stimulates Human β-Cell Proliferation. Diabetes 2016, 65, 1660–1671. [Google Scholar] [CrossRef] [Green Version]
- Shen, W.; Taylor, B.; Jin, Q.; Nguyen-Tran, V.; Meeusen, S.; Zhang, Y.Q.; Kamireddy, A.; Swafford, A.; Powers, A.F.; Walker, J.; et al. Inhibition of DYRK1A and GSK3B induces human β-cell proliferation. Nat. Commun. 2015, 6, 8372. [Google Scholar] [CrossRef] [Green Version]
- Wang, P.; Karakose, E.; Liu, H.; Swartz, E.; Ackeifi, C.; Zlatanic, V.; Wilson, J.; González, B.J.; Bender, A.; Takane, K.K.; et al. Combined Inhibition of DYRK1A, SMAD, and Trithorax Pathways Synergizes to Induce Robust Replication in Adult Human Beta Cells. Cell Metab. 2019, 29, 638–652.e635. [Google Scholar] [CrossRef] [Green Version]
- Ackeifi, C.; Wang, P.; Karakose, E.; Manning Fox, J.E.; González, B.J.; Liu, H.; Wilson, J.; Swartz, E.; Berrouet, C.; Li, Y.; et al. GLP-1 receptor agonists synergize with DYRK1A inhibitors to potentiate functional human β cell regeneration. Sci. Transl. Med. 2020, 12, eaaw9996. [Google Scholar] [CrossRef]
- Wang, P.; Karakose, E.; Choleva, L.; Kumar, K.; DeVita, R.J.; Garcia-Ocaña, A.; Stewart, A.F. Human Beta Cell Regenerative Drug Therapy for Diabetes: Past Achievements and Future Challenges. Front. Endocrinol. 2021, 12, 671946. [Google Scholar] [CrossRef]
- Chung, C.H.; Hao, E.; Piran, R.; Keinan, E.; Levine, F. Pancreatic β-cell neogenesis by direct conversion from mature α-cells. Stem Cells 2010, 28, 1630–1638. [Google Scholar] [CrossRef]
- Wang, R.N.; Klöppel, G.; Bouwens, L. Duct- to islet-cell differentiation and islet growth in the pancreas of duct-ligated adult rats. Diabetologia 1995, 38, 1405–1411. [Google Scholar] [CrossRef]
- Pan, F.C.; Bankaitis, E.D.; Boyer, D.; Xu, X.; Van de Casteele, M.; Magnuson, M.A.; Heimberg, H.; Wright, C.V. Spatiotemporal patterns of multipotentiality in Ptf1a-expressing cells during pancreas organogenesis and injury-induced facultative restoration. Development 2013, 140, 751–764. [Google Scholar] [CrossRef] [Green Version]
- Xu, X.; D’Hoker, J.; Stangé, G.; Bonné, S.; De Leu, N.; Xiao, X.; Van de Casteele, M.; Mellitzer, G.; Ling, Z.; Pipeleers, D.; et al. Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell 2008, 132, 197–207. [Google Scholar] [CrossRef] [Green Version]
- Cavelti-Weder, C.; Shtessel, M.; Reuss, J.E.; Jermendy, A.; Yamada, T.; Caballero, F.; Bonner-Weir, S.; Weir, G.C. Pancreatic duct ligation after almost complete β-cell loss: Exocrine regeneration but no evidence of β-cell regeneration. Endocrinology 2013, 154, 4493–4502. [Google Scholar] [CrossRef]
- Zhou, Q.; Brown, J.; Kanarek, A.; Rajagopal, J.; Melton, D.A. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 2008, 455, 627–632. [Google Scholar] [CrossRef]
- Xiao, X.; Guo, P.; Shiota, C.; Zhang, T.; Coudriet, G.M.; Fischbach, S.; Prasadan, K.; Fusco, J.; Ramachandran, S.; Witkowski, P.; et al. Endogenous Reprogramming of Alpha Cells into Beta Cells, Induced by Viral Gene Therapy, Reverses Autoimmune Diabetes. Cell Stem Cell 2018, 22, 78–90.e4. [Google Scholar] [CrossRef] [Green Version]
- Pagliuca, F.W.; Millman, J.R.; Gürtler, M.; Segel, M.; Van Dervort, A.; Ryu, J.H.; Peterson, Q.P.; Greiner, D.; Melton, D.A. Generation of functional human pancreatic β cells in vitro. Cell 2014, 159, 428–439. [Google Scholar] [CrossRef] [Green Version]
- Rezania, A.; Bruin, J.E.; Arora, P.; Rubin, A.; Batushansky, I.; Asadi, A.; O’Dwyer, S.; Quiskamp, N.; Mojibian, M.; Albrecht, T.; et al. Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells. Nat. Biotechnol. 2014, 32, 1121–1133. [Google Scholar] [CrossRef]
- Russ, H.A.; Parent, A.V.; Ringler, J.J.; Hennings, T.G.; Nair, G.G.; Shveygert, M.; Guo, T.; Puri, S.; Haataja, L.; Cirulli, V.; et al. Controlled induction of human pancreatic progenitors produces functional beta-like cells in vitro. EMBO J. 2015, 34, 1759–1772. [Google Scholar] [CrossRef] [Green Version]
- Veres, A.; Faust, A.L.; Bushnell, H.L.; Engquist, E.N.; Kenty, J.H.; Harb, G.; Poh, Y.C.; Sintov, E.; Gürtler, M.; Pagliuca, F.W.; et al. Charting cellular identity during human in vitro β-cell differentiation. Nature 2019, 569, 368–373. [Google Scholar] [CrossRef]
- Hebrok, M. Hedgehog signaling in pancreas development. Mech. Dev. 2003, 120, 45–57. [Google Scholar] [CrossRef]
- Murtaugh, L.C.; Melton, D.A. Genes, signals, and lineages in pancreas development. Annu. Rev. Cell Dev. Biol. 2003, 19, 71–89. [Google Scholar] [CrossRef]
- Pan, F.C.; Wright, C. Pancreas organogenesis: From bud to plexus to gland. Dev. Dyn. 2011, 240, 530–565. [Google Scholar] [CrossRef]
- Seymour, P.A.; Sander, M. Historical perspective: Beginnings of the beta-cell: Current perspectives in beta-cell development. Diabetes 2011, 60, 364–376. [Google Scholar] [CrossRef] [Green Version]
- D’Amour, K.A.; Agulnick, A.D.; Eliazer, S.; Kelly, O.G.; Kroon, E.; Baetge, E.E. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat. Biotechnol. 2005, 23, 1534–1541. [Google Scholar] [CrossRef]
- D’Amour, K.A.; Bang, A.G.; Eliazer, S.; Kelly, O.G.; Agulnick, A.D.; Smart, N.G.; Moorman, M.A.; Kroon, E.; Carpenter, M.K.; Baetge, E.E. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat. Biotechnol. 2006, 24, 1392–1401. [Google Scholar] [CrossRef]
- Kroon, E.; Martinson, L.A.; Kadoya, K.; Bang, A.G.; Kelly, O.G.; Eliazer, S.; Young, H.; Richardson, M.; Smart, N.G.; Cunningham, J.; et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat. Biotechnol. 2008, 26, 443–452. [Google Scholar] [CrossRef]
- Gouon-Evans, V.; Boussemart, L.; Gadue, P.; Nierhoff, D.; Koehler, C.I.; Kubo, A.; Shafritz, D.A.; Keller, G. BMP-4 is required for hepatic specification of mouse embryonic stem cell-derived definitive endoderm. Nat. Biotechnol. 2006, 24, 1402–1411. [Google Scholar] [CrossRef]
- Hebrok, M.; Kim, S.K.; Melton, D.A. Notochord repression of endodermal Sonic hedgehog permits pancreas development. Genes Dev. 1998, 12, 1705–1713. [Google Scholar] [CrossRef] [Green Version]
- Nostro, M.C.; Sarangi, F.; Yang, C.; Holland, A.; Elefanty, A.G.; Stanley, E.G.; Greiner, D.L.; Keller, G. Efficient generation of NKX6-1+ pancreatic progenitors from multiple human pluripotent stem cell lines. Stem Cell Rep. 2015, 4, 591–604. [Google Scholar] [CrossRef] [Green Version]
- Rezania, A.; Bruin, J.E.; Riedel, M.J.; Mojibian, M.; Asadi, A.; Xu, J.; Gauvin, R.; Narayan, K.; Karanu, F.; O’Neil, J.J.; et al. Maturation of human embryonic stem cell-derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice. Diabetes 2012, 61, 2016–2029. [Google Scholar] [CrossRef] [Green Version]
- Chen, S.; Borowiak, M.; Fox, J.L.; Maehr, R.; Osafune, K.; Davidow, L.; Lam, K.; Peng, L.F.; Schreiber, S.L.; Rubin, L.L.; et al. A small molecule that directs differentiation of human ESCs into the pancreatic lineage. Nat. Chem. Biol. 2009, 5, 258–265. [Google Scholar] [CrossRef]
- Nostro, M.C.; Sarangi, F.; Ogawa, S.; Holtzinger, A.; Corneo, B.; Li, X.; Micallef, S.J.; Park, I.H.; Basford, C.; Wheeler, M.B.; et al. Stage-specific signaling through TGFβ family members and WNT regulates patterning and pancreatic specification of human pluripotent stem cells. Development 2011, 138, 861–871. [Google Scholar] [CrossRef] [Green Version]
- Velazco-Cruz, L.; Goedegebuure, M.M.; Maxwell, K.G.; Augsornworawat, P.; Hogrebe, N.J.; Millman, J.R. SIX2 Regulates Human β Cell Differentiation from Stem Cells and Functional Maturation In Vitro. Cell Rep. 2020, 31, 107687. [Google Scholar] [CrossRef]
- Zhu, S.; Russ, H.A.; Wang, X.; Zhang, M.; Ma, T.; Xu, T.; Tang, S.; Hebrok, M.; Ding, S. Human pancreatic beta-like cells converted from fibroblasts. Nat. Commun. 2016, 7, 10080. [Google Scholar] [CrossRef] [Green Version]
- Zhou, X.; Nair, G.G.; Russ, H.A.; Belair, C.D.; Li, M.L.; Shveygert, M.; Hebrok, M.; Blelloch, R. LIN28B Impairs the Transition of hESC-Derived β Cells from the Juvenile to Adult State. Stem Cell Rep. 2020, 14, 9–20. [Google Scholar] [CrossRef] [Green Version]
- Velazco-Cruz, L.; Song, J.; Maxwell, K.G.; Goedegebuure, M.M.; Augsornworawat, P.; Hogrebe, N.J.; Millman, J.R. Acquisition of Dynamic Function in Human Stem Cell-Derived β Cells. Stem Cell Rep. 2019, 12, 351–365. [Google Scholar] [CrossRef] [Green Version]
- Docherty, F.M.; Riemondy, K.A.; Castro-Gutierrez, R.; Dwulet, J.M.; Shilleh, A.H.; Hansen, M.S.; Williams, S.P.M.; Armitage, L.H.; Santostefano, K.E.; Wallet, M.A.; et al. ENTPD3 Marks Mature Stem Cell-Derived β-Cells Formed by Self-Aggregation In Vitro. Diabetes 2021, 70, 2554–2567. [Google Scholar] [CrossRef]
- Nair, G.G.; Liu, J.S.; Russ, H.A.; Tran, S.; Saxton, M.S.; Chen, R.; Juang, C.; Li, M.L.; Nguyen, V.Q.; Giacometti, S.; et al. Recapitulating endocrine cell clustering in culture promotes maturation of human stem-cell-derived beta cells. Nat. Cell Biol. 2019, 21, 263–274. [Google Scholar] [CrossRef]
- Molakandov, K.; Berti, D.A.; Beck, A.; Elhanani, O.; Walker, M.D.; Soen, Y.; Yavriyants, K.; Zimerman, M.; Volman, E.; Toledo, I.; et al. Selection for CD26. Front. Endocrinol. 2021, 12, 635405. [Google Scholar] [CrossRef]
- Kaestner, K.H.; Campbell-Thompson, M.; Dor, Y.; Gill, R.G.; Glaser, B.; Kim, S.K.; Sander, M.; Stabler, C.; Stewart, A.F.; Powers, A.C. What is a β cell?—Chapter I in the Human Islet Research Network (HIRN) review series. Mol. Metab. 2021, 53, 101323. [Google Scholar] [CrossRef]
- Augsornworawat, P.; Maxwell, K.G.; Velazco-Cruz, L.; Millman, J.R. Single-Cell Transcriptome Profiling Reveals β Cell Maturation in Stem Cell-Derived Islets after Transplantation. Cell Rep. 2020, 32, 108067. [Google Scholar] [CrossRef]
- Balboa, D.; Barsby, T.; Lithovius, V.; Saarimäki-Vire, J.; Omar-Hmeadi, M.; Dyachok, O.; Montaser, H.; Lund, P.E.; Yang, M.; Ibrahim, H.; et al. Functional, metabolic and transcriptional maturation of human pancreatic islets derived from stem cells. Nat. Biotechnol. 2022, 40, 1042–1055. [Google Scholar] [CrossRef]
- Faleo, G.; Russ, H.A.; Wisel, S.; Parent, A.V.; Nguyen, V.; Nair, G.G.; Freise, J.E.; Villanueva, K.E.; Szot, G.L.; Hebrok, M.; et al. Mitigating Ischemic Injury of Stem Cell-Derived Insulin-Producing Cells after Transplant. Stem Cell Rep. 2017, 9, 807–819. [Google Scholar] [CrossRef] [Green Version]
- Paraskevas, S.; Maysinger, D.; Wang, R.; Duguid, T.P.; Rosenberg, L. Cell loss in isolated human islets occurs by apoptosis. Pancreas 2000, 20, 270–276. [Google Scholar] [CrossRef]
- McKenzie, M.D.; Jamieson, E.; Jansen, E.S.; Scott, C.L.; Huang, D.C.; Bouillet, P.; Allison, J.; Kay, T.W.; Strasser, A.; Thomas, H.E. Glucose induces pancreatic islet cell apoptosis that requires the BH3-only proteins Bim and Puma and multi-BH domain protein Bax. Diabetes 2010, 59, 644–652. [Google Scholar] [CrossRef] [Green Version]
- Federici, M.; Hribal, M.; Perego, L.; Ranalli, M.; Caradonna, Z.; Perego, C.; Usellini, L.; Nano, R.; Bonini, P.; Bertuzzi, F.; et al. High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: A potential role for regulation of specific Bcl family genes toward an apoptotic cell death program. Diabetes 2001, 50, 1290–1301. [Google Scholar] [CrossRef] [Green Version]
- Costes, S.; Vandewalle, B.; Tourrel-Cuzin, C.; Broca, C.; Linck, N.; Bertrand, G.; Kerr-Conte, J.; Portha, B.; Pattou, F.; Bockaert, J.; et al. Degradation of cAMP-responsive element-binding protein by the ubiquitin-proteasome pathway contributes to glucotoxicity in beta-cells and human pancreatic islets. Diabetes 2009, 58, 1105–1115. [Google Scholar] [CrossRef] [Green Version]
- McCall, M.; Pawlick, R.; Kin, T.; Shapiro, A.M. Anakinra potentiates the protective effects of etanercept in transplantation of marginal mass human islets in immunodeficient mice. Am. J. Transplant. 2012, 12, 322–329. [Google Scholar] [CrossRef]
- Ricordi, C.; Lacy, P.E.; Finke, E.H.; Olack, B.J.; Scharp, D.W. Automated method for isolation of human pancreatic islets. Diabetes 1988, 37, 413–420. [Google Scholar] [CrossRef]
- Nikolova, G.; Jabs, N.; Konstantinova, I.; Domogatskaya, A.; Tryggvason, K.; Sorokin, L.; Fässler, R.; Gu, G.; Gerber, H.P.; Ferrara, N.; et al. The vascular basement membrane: A niche for insulin gene expression and Beta cell proliferation. Dev. Cell 2006, 10, 397–405. [Google Scholar] [CrossRef] [Green Version]
- Linn, T.; Schmitz, J.; Hauck-Schmalenberger, I.; Lai, Y.; Bretzel, R.G.; Brandhorst, H.; Brandhorst, D. Ischaemia is linked to inflammation and induction of angiogenesis in pancreatic islets. Clin. Exp. Immunol. 2006, 144, 179–187. [Google Scholar] [CrossRef]
- Olsson, R.; Carlsson, P.O. Oxygenation of cultured pancreatic islets. Adv. Exp. Med. Biol. 2006, 578, 263–268. [Google Scholar] [CrossRef]
- Maechler, P.; de Andrade, P.B. Mitochondrial damages and the regulation of insulin secretion. Biochem. Soc. Trans. 2006, 34, 824–827. [Google Scholar] [CrossRef] [Green Version]
- Carlsson, P.O.; Liss, P.; Andersson, A.; Jansson, L. Measurements of oxygen tension in native and transplanted rat pancreatic islets. Diabetes 1998, 47, 1027–1032. [Google Scholar] [CrossRef]
- Carlsson, P.O.; Palm, F.; Andersson, A.; Liss, P. Chronically decreased oxygen tension in rat pancreatic islets transplanted under the kidney capsule. Transplantation 2000, 69, 761–766. [Google Scholar] [CrossRef]
- Carlsson, P.O.; Palm, F.; Andersson, A.; Liss, P. Markedly decreased oxygen tension in transplanted rat pancreatic islets irrespective of the implantation site. Diabetes 2001, 50, 489–495. [Google Scholar] [CrossRef] [Green Version]
- Davalli, A.M.; Ogawa, Y.; Ricordi, C.; Scharp, D.W.; Bonner-Weir, S.; Weir, G.C. A selective decrease in the beta cell mass of human islets transplanted into diabetic nude mice. Transplantation 1995, 59, 817–820. [Google Scholar]
- Carlsson, P.O.; Palm, F.; Mattsson, G. Low revascularization of experimentally transplanted human pancreatic islets. J. Clin. Endocrinol. Metab. 2002, 87, 5418–5423. [Google Scholar] [CrossRef] [Green Version]
- Stokes, R.A.; Cheng, K.; Deters, N.; Lau, S.M.; Hawthorne, W.J.; O’Connell, P.J.; Stolp, J.; Grey, S.; Loudovaris, T.; Kay, T.W.; et al. Hypoxia-inducible factor-1α (HIF-1α) potentiates β-cell survival after islet transplantation of human and mouse islets. Cell Transplant. 2013, 22, 253–266. [Google Scholar] [CrossRef]
- Rodriguez-Brotons, A.; Bietiger, W.; Peronet, C.; Magisson, J.; Sookhareea, C.; Langlois, A.; Mura, C.; Jeandidier, N.; Pinget, M.; Sigrist, S.; et al. Impact of Pancreatic Rat Islet Density on Cell Survival during Hypoxia. J. Diabetes Res. 2016, 2016, 3615286. [Google Scholar] [CrossRef] [Green Version]
- Komatsu, H.; Kang, D.; Medrano, L.; Barriga, A.; Mendez, D.; Rawson, J.; Omori, K.; Ferreri, K.; Tai, Y.C.; Kandeel, F.; et al. Isolated human islets require hyperoxia to maintain islet mass, metabolism, and function. Biochem. Biophys. Res. Commun. 2016, 470, 534–538. [Google Scholar] [CrossRef] [Green Version]
- Komatsu, H.; Cook, C.; Wang, C.H.; Medrano, L.; Lin, H.; Kandeel, F.; Tai, Y.C.; Mullen, Y. Oxygen environment and islet size are the primary limiting factors of isolated pancreatic islet survival. PLoS ONE 2017, 12, e0183780. [Google Scholar] [CrossRef] [Green Version]
- Garcia-Contreras, M.; Tamayo-Garcia, A.; Pappan, K.L.; Michelotti, G.A.; Stabler, C.L.; Ricordi, C.; Buchwald, P. Metabolomics Study of the Effects of Inflammation, Hypoxia, and High Glucose on Isolated Human Pancreatic Islets. J. Proteome Res. 2017, 16, 2294–2306. [Google Scholar] [CrossRef]
- Maillard, E.; Juszczak, M.T.; Langlois, A.; Kleiss, C.; Sencier, M.C.; Bietiger, W.; Sanchez-Dominguez, M.; Krafft, M.P.; Johnson, P.R.; Pinget, M.; et al. Perfluorocarbon emulsions prevent hypoxia of pancreatic β-cells. Cell Transplant. 2012, 21, 657–669. [Google Scholar] [CrossRef] [Green Version]
- Cantley, J.; Grey, S.T.; Maxwell, P.H.; Withers, D.J. The hypoxia response pathway and β-cell function. Diabetes Obes. Metab. 2010, 12 (Suppl. S2), 159–167. [Google Scholar] [CrossRef]
- Cheng, K.; Ho, K.; Stokes, R.; Scott, C.; Lau, S.M.; Hawthorne, W.J.; O’Connell, P.J.; Loudovaris, T.; Kay, T.W.; Kulkarni, R.N.; et al. Hypoxia-inducible factor-1alpha regulates beta cell function in mouse and human islets. J. Clin. Investig. 2010, 120, 2171–2183. [Google Scholar] [CrossRef] [Green Version]
- Cantley, J.; Walters, S.N.; Jung, M.H.; Weinberg, A.; Cowley, M.J.; Whitworth, T.P.; Kaplan, W.; Hawthorne, W.J.; O’Connell, P.J.; Weir, G.; et al. A preexistent hypoxic gene signature predicts impaired islet graft function and glucose homeostasis. Cell Transplant. 2013, 22, 2147–2159. [Google Scholar] [CrossRef]
- Moritz, W.; Meier, F.; Stroka, D.M.; Giuliani, M.; Kugelmeier, P.; Nett, P.C.; Lehmann, R.; Candinas, D.; Gassmann, M.; Weber, M. Apoptosis in hypoxic human pancreatic islets correlates with HIF-1alpha expression. FASEB J. 2002, 16, 745–747. [Google Scholar] [CrossRef]
- Zhou, R.; Tardivel, A.; Thorens, B.; Choi, I.; Tschopp, J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 2010, 11, 136–140. [Google Scholar] [CrossRef]
- Wali, J.A.; Gurzov, E.N.; Fynch, S.; Elkerbout, L.; Kay, T.W.; Masters, S.L.; Thomas, H.E. Activation of the NLRP3 inflammasome complex is not required for stress-induced death of pancreatic islets. PLoS ONE 2014, 9, e113128. [Google Scholar] [CrossRef]
- do Amaral, A.S.; Pawlick, R.L.; Rodrigues, E.; Costal, F.; Pepper, A.; Galvão, F.H.; Correa-Giannella, M.L.; Shapiro, A.M. Glutathione ethyl ester supplementation during pancreatic islet isolation improves viability and transplant outcomes in a murine marginal islet mass model. PLoS ONE 2013, 8, e55288. [Google Scholar] [CrossRef] [Green Version]
- Miwa, I.; Ichimura, N.; Sugiura, M.; Hamada, Y.; Taniguchi, S. Inhibition of glucose-induced insulin secretion by 4-hydroxy-2-nonenal and other lipid peroxidation products. Endocrinology 2000, 141, 2767–2772. [Google Scholar] [CrossRef]
- Carobbio, S.; Ishihara, H.; Fernandez-Pascual, S.; Bartley, C.; Martin-Del-Rio, R.; Maechler, P. Insulin secretion profiles are modified by overexpression of glutamate dehydrogenase in pancreatic islets. Diabetologia 2004, 47, 266–276. [Google Scholar] [CrossRef] [Green Version]
- Li, C.; Buettger, C.; Kwagh, J.; Matter, A.; Daikhin, Y.; Nissim, I.B.; Collins, H.W.; Yudkoff, M.; Stanley, C.A.; Matschinsky, F.M. A signaling role of glutamine in insulin secretion. J. Biol. Chem. 2004, 279, 13393–13401. [Google Scholar] [CrossRef] [Green Version]
- Koulajian, K.; Ivovic, A.; Ye, K.; Desai, T.; Shah, A.; Fantus, I.G.; Ran, Q.; Giacca, A. Overexpression of glutathione peroxidase 4 prevents β-cell dysfunction induced by prolonged elevation of lipids in vivo. Am. J. Physiol. Endocrinol. Metab. 2013, 305, E254–E262. [Google Scholar] [CrossRef] [Green Version]
- Skouta, R.; Dixon, S.J.; Wang, J.; Dunn, D.E.; Orman, M.; Shimada, K.; Rosenberg, P.A.; Lo, D.C.; Weinberg, J.M.; Linkermann, A.; et al. Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models. J. Am. Chem. Soc. 2014, 136, 4551–4556. [Google Scholar] [CrossRef]
- Kaczmarek, A.; Vandenabeele, P.; Krysko, D.V. Necroptosis: The release of damage-associated molecular patterns and its physiological relevance. Immunity 2013, 38, 209–223. [Google Scholar] [CrossRef] [Green Version]
- Daly, K.A.; Liu, S.; Agrawal, V.; Brown, B.N.; Johnson, S.A.; Medberry, C.J.; Badylak, S.F. Damage associated molecular patterns within xenogeneic biologic scaffolds and their effects on host remodeling. Biomaterials 2012, 33, 91–101. [Google Scholar] [CrossRef]
- Paredes-Juarez, G.A.; Sahasrabudhe, N.M.; Tjoelker, R.S.; de Haan, B.J.; Engelse, M.A.; de Koning, E.J.P.; Faas, M.M.; de Vos, P. DAMP production by human islets under low oxygen and nutrients in the presence or absence of an immunoisolating-capsule and necrostatin-1. Sci. Rep. 2015, 5, 14623. [Google Scholar] [CrossRef] [Green Version]
- Land, W.G.; Agostinis, P.; Gasser, S.; Garg, A.D.; Linkermann, A. DAMP-Induced Allograft and Tumor Rejection: The Circle Is Closing. Am. J. Transplant. 2016, 16, 3322–3337. [Google Scholar] [CrossRef]
- Land, W.G.; Agostinis, P.; Gasser, S.; Garg, A.D.; Linkermann, A. Transplantation and Damage-Associated Molecular Patterns (DAMPs). Am. J. Transplant. 2016, 16, 3338–3361. [Google Scholar] [CrossRef]
- Itoh, T.; Takita, M.; SoRelle, J.A.; Shimoda, M.; Sugimoto, K.; Chujo, D.; Qin, H.; Naziruddin, B.; Levy, M.F.; Matsumoto, S. Correlation of released HMGB1 levels with the degree of islet damage in mice and humans and with the outcomes of islet transplantation in mice. Cell Transplant. 2012, 21, 1371–1381. [Google Scholar] [CrossRef]
- Pepper, A.R.; Gala-Lopez, B.; Pawlick, R.; Merani, S.; Kin, T.; Shapiro, A.M. A prevascularized subcutaneous device-less site for islet and cellular transplantation. Nat. Biotechnol. 2015, 33, 518–523. [Google Scholar] [CrossRef]
- Vlahos, A.E.; Cober, N.; Sefton, M.V. Modular tissue engineering for the vascularization of subcutaneously transplanted pancreatic islets. Proc. Natl. Acad. Sci. USA 2017, 114, 9337–9342. [Google Scholar] [CrossRef] [Green Version]
- Song, W.; Chiu, A.; Wang, L.H.; Schwartz, R.E.; Li, B.; Bouklas, N.; Bowers, D.T.; An, D.; Cheong, S.H.; Flanders, J.A.; et al. Engineering transferrable microvascular meshes for subcutaneous islet transplantation. Nat. Commun. 2019, 10, 4602. [Google Scholar] [CrossRef] [Green Version]
- Yu, M.; Agarwal, D.; Korutla, L.; May, C.L.; Wang, W.; Griffith, N.N.; Hering, B.J.; Kaestner, K.H.; Velazquez, O.C.; Markmann, J.F.; et al. Islet transplantation in the subcutaneous space achieves long-term euglycaemia in preclinical models of type 1 diabetes. Nat. Metab. 2020, 2, 1013–1020. [Google Scholar] [CrossRef]
- Butler, M.J.; Sefton, M.V. Cotransplantation of adipose-derived mesenchymal stromal cells and endothelial cells in a modular construct drives vascularization in SCID/bg mice. Tissue Eng. Part A 2012, 18, 1628–1641. [Google Scholar] [CrossRef] [Green Version]
- Weaver, J.D.; Headen, D.M.; Aquart, J.; Johnson, C.T.; Shea, L.D.; Shirwan, H.; García, A.J. Vasculogenic hydrogel enhances islet survival, engraftment, and function in leading extrahepatic sites. Sci. Adv. 2017, 3, e1700184. [Google Scholar] [CrossRef] [Green Version]
- Aghazadeh, Y.; Poon, F.; Sarangi, F.; Wong, F.T.M.; Khan, S.T.; Sun, X.; Hatkar, R.; Cox, B.J.; Nunes, S.S.; Nostro, M.C. Microvessels support engraftment and functionality of human islets and hESC-derived pancreatic progenitors in diabetes models. Cell Stem Cell 2021, 28, 1936–1949.e8. [Google Scholar] [CrossRef]
- Coronel, M.M.; Geusz, R.; Stabler, C.L. Mitigating hypoxic stress on pancreatic islets via in situ oxygen generating biomaterial. Biomaterials 2017, 129, 139–151. [Google Scholar] [CrossRef]
- Coronel, M.M.; Liang, J.P.; Li, Y.; Stabler, C.L. Oxygen generating biomaterial improves the function and efficacy of beta cells within a macroencapsulation device. Biomaterials 2019, 210, 1–11. [Google Scholar] [CrossRef]
- Liang, J.P.; Accolla, R.P.; Soundirarajan, M.; Emerson, A.; Coronel, M.M.; Stabler, C.L. Engineering a macroporous oxygen-generating scaffold for enhancing islet cell transplantation within an extrahepatic site. Acta Biomater. 2021, 130, 268–280. [Google Scholar] [CrossRef]
- Santini-González, J.; Simonovich, J.A.; Castro-Gutiérrez, R.; González-Vargas, Y.; Abuid, N.J.; Stabler, C.L.; Russ, H.A.; Phelps, E.A. In vitro generation of peri-islet basement membrane-like structures. Biomaterials 2021, 273, 120808. [Google Scholar] [CrossRef]
- Takahashi, Y.; Sekine, K.; Kin, T.; Takebe, T.; Taniguchi, H. Self-Condensation Culture Enables Vascularization of Tissue Fragments for Efficient Therapeutic Transplantation. Cell Rep. 2018, 23, 1620–1629. [Google Scholar] [CrossRef] [Green Version]
- Holmberg, J.; Perlmann, T. Maintaining differentiated cellular identity. Nat. Rev. Genet. 2012, 13, 429–439. [Google Scholar] [CrossRef]
- Weir, G.C.; Aguayo-Mazzucato, C.; Bonner-Weir, S. β-cell dedifferentiation in diabetes is important, but what is it? Islets 2013, 5, 233–237. [Google Scholar] [CrossRef] [Green Version]
- Bensellam, M.; Laybutt, D.R.; Jonas, J.C. The molecular mechanisms of pancreatic β-cell glucotoxicity: Recent findings and future research directions. Mol. Cell Endocrinol. 2012, 364, 1–27. [Google Scholar] [CrossRef]
- Bensellam, M.; Jonas, J.C.; Laybutt, D.R. Mechanisms of β-cell dedifferentiation in diabetes: Recent findings and future research directions. J. Endocrinol. 2018, 236, R109–R143. [Google Scholar] [CrossRef] [Green Version]
- Talchai, C.; Xuan, S.; Lin, H.V.; Sussel, L.; Accili, D. Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure. Cell 2012, 150, 1223–1234. [Google Scholar] [CrossRef] [Green Version]
- Kim-Muller, J.Y.; Zhao, S.; Srivastava, S.; Mugabo, Y.; Noh, H.L.; Kim, Y.R.; Madiraju, S.R.; Ferrante, A.W.; Skolnik, E.Y.; Prentki, M.; et al. Metabolic inflexibility impairs insulin secretion and results in MODY-like diabetes in triple FoxO-deficient mice. Cell Metab. 2014, 20, 593–602. [Google Scholar] [CrossRef] [Green Version]
- Guo, S.; Dai, C.; Guo, M.; Taylor, B.; Harmon, J.S.; Sander, M.; Robertson, R.P.; Powers, A.C.; Stein, R. Inactivation of specific β cell transcription factors in type 2 diabetes. J. Clin. Investig. 2013, 123, 3305–3316. [Google Scholar] [CrossRef] [Green Version]
- Kim-Muller, J.Y.; Fan, J.; Kim, Y.J.; Lee, S.A.; Ishida, E.; Blaner, W.S.; Accili, D. Aldehyde dehydrogenase 1a3 defines a subset of failing pancreatic β cells in diabetic mice. Nat. Commun. 2016, 7, 12631. [Google Scholar] [CrossRef] [Green Version]
- Cinti, F.; Bouchi, R.; Kim-Muller, J.Y.; Ohmura, Y.; Sandoval, P.R.; Masini, M.; Marselli, L.; Suleiman, M.; Ratner, L.E.; Marchetti, P.; et al. Evidence of β-Cell Dedifferentiation in Human Type 2 Diabetes. J. Clin. Endocrinol. Metab. 2016, 101, 1044–1054. [Google Scholar] [CrossRef] [Green Version]
- Ishida, E.; Kim-Muller, J.Y.; Accili, D. Pair Feeding, but Not Insulin, Phloridzin, or Rosiglitazone Treatment, Curtails Markers of β-Cell Dedifferentiation in. Diabetes 2017, 66, 2092–2101. [Google Scholar] [CrossRef] [Green Version]
- Stancill, J.S.; Cartailler, J.P.; Clayton, H.W.; O’Connor, J.T.; Dickerson, M.T.; Dadi, P.K.; Osipovich, A.B.; Jacobson, D.A.; Magnuson, M.A. Chronic β-Cell Depolarization Impairs β-Cell Identity by Disrupting a Network of Ca. Diabetes 2017, 66, 2175–2187. [Google Scholar] [CrossRef] [Green Version]
- Kaelin, W.G. The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer. Nat. Rev. Cancer 2008, 8, 865–873. [Google Scholar] [CrossRef]
- Semenza, G.L. HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations. J. Clin. Investig. 2013, 123, 3664–3671. [Google Scholar] [CrossRef] [Green Version]
- Puri, S.; Akiyama, H.; Hebrok, M. VHL-mediated disruption of Sox9 activity compromises beta-cell identity and results in diabetes mellitus. Genes Dev. 2013, 27, 2563–2575. [Google Scholar] [CrossRef] [Green Version]
- Beattie, G.M.; Itkin-Ansari, P.; Cirulli, V.; Leibowitz, G.; Lopez, A.D.; Bossie, S.; Mally, M.I.; Levine, F.; Hayek, A. Sustained proliferation of PDX-1+ cells derived from human islets. Diabetes 1999, 48, 1013–1019. [Google Scholar] [CrossRef]
- Beattie, G.M.; Leibowitz, G.; Lopez, A.D.; Levine, F.; Hayek, A. Protection from cell death in cultured human fetal pancreatic cells. Cell Transplant. 2000, 9, 431–438. [Google Scholar] [CrossRef]
- Beattie, G.M.; Montgomery, A.M.; Lopez, A.D.; Hao, E.; Perez, B.; Just, M.L.; Lakey, J.R.; Hart, M.E.; Hayek, A. A novel approach to increase human islet cell mass while preserving beta-cell function. Diabetes 2002, 51, 3435–3439. [Google Scholar] [CrossRef] [Green Version]
- Halvorsen, T.L.; Beattie, G.M.; Lopez, A.D.; Hayek, A.; Levine, F. Accelerated telomere shortening and senescence in human pancreatic islet cells stimulated to divide in vitro. J. Endocrinol. 2000, 166, 103–109. [Google Scholar] [CrossRef]
- Gershengorn, M.C.; Hardikar, A.A.; Wei, C.; Geras-Raaka, E.; Marcus-Samuels, B.; Raaka, B.M. Epithelial-to-mesenchymal transition generates proliferative human islet precursor cells. Science 2004, 306, 2261–2264. [Google Scholar] [CrossRef] [Green Version]
- Russ, H.A.; Bar, Y.; Ravassard, P.; Efrat, S. In vitro proliferation of cells derived from adult human beta-cells revealed by cell-lineage tracing. Diabetes 2008, 57, 1575–1583. [Google Scholar] [CrossRef] [Green Version]
- Joglekar, M.V.; Joglekar, V.M.; Joglekar, S.V.; Hardikar, A.A. Human fetal pancreatic insulin-producing cells proliferate in vitro. J. Endocrinol. 2009, 201, 27–36. [Google Scholar] [CrossRef] [Green Version]
- Russ, H.A.; Ravassard, P.; Kerr-Conte, J.; Pattou, F.; Efrat, S. Epithelial-mesenchymal transition in cells expanded in vitro from lineage-traced adult human pancreatic beta cells. PLoS ONE 2009, 4, e6417. [Google Scholar] [CrossRef]
- Friedman-Mazursky, O.; Elkon, R.; Efrat, S. Redifferentiation of expanded human islet β cells by inhibition of ARX. Sci. Rep. 2016, 6, 20698. [Google Scholar] [CrossRef] [Green Version]
- Russ, H.A.; Sintov, E.; Anker-Kitai, L.; Friedman, O.; Lenz, A.; Toren, G.; Farhy, C.; Pasmanik-Chor, M.; Oron-Karni, V.; Ravassard, P.; et al. Insulin-producing cells generated from dedifferentiated human pancreatic beta cells expanded in vitro. PLoS ONE 2011, 6, e25566. [Google Scholar] [CrossRef] [Green Version]
- Sintov, E.; Nathan, G.; Knoller, S.; Pasmanik-Chor, M.; Russ, H.A.; Efrat, S. Inhibition of ZEB1 expression induces redifferentiation of adult human β cells expanded in vitro. Sci. Rep. 2015, 5, 13024. [Google Scholar] [CrossRef] [Green Version]
- Toren-Haritan, G.; Efrat, S. TGFβ Pathway Inhibition Redifferentiates Human Pancreatic Islet β Cells Expanded In Vitro. PLoS ONE 2015, 10, e0139168. [Google Scholar] [CrossRef]
- Lenz, A.; Toren-Haritan, G.; Efrat, S. Redifferentiation of adult human β cells expanded in vitro by inhibition of the WNT pathway. PLoS ONE 2014, 9, e112914. [Google Scholar] [CrossRef]
- Bar, Y.; Russ, H.A.; Sintov, E.; Anker-Kitai, L.; Knoller, S.; Efrat, S. Redifferentiation of expanded human pancreatic β-cell-derived cells by inhibition of the NOTCH pathway. J. Biol. Chem. 2012, 287, 17269–17280. [Google Scholar] [CrossRef] [Green Version]
- Weinberg, N.; Ouziel-Yahalom, L.; Knoller, S.; Efrat, S.; Dor, Y. Lineage tracing evidence for in vitro dedifferentiation but rare proliferation of mouse pancreatic beta-cells. Diabetes 2007, 56, 1299–1304. [Google Scholar] [CrossRef] [Green Version]
- Md Moin, A.S.; Dhawan, S.; Cory, M.; Butler, P.C.; Rizza, R.A.; Butler, A.E. Increased Frequency of Hormone Negative and Polyhormonal Endocrine Cells in Lean Individuals With Type 2 Diabetes. J. Clin. Endocrinol. Metab. 2016, 101, 3628–3636. [Google Scholar] [CrossRef] [Green Version]
- Md Moin, A.S.; Dhawan, S.; Shieh, C.; Butler, P.C.; Cory, M.; Butler, A.E. Increased Hormone-Negative Endocrine Cells in the Pancreas in Type 1 Diabetes. J. Clin. Endocrinol. Metab. 2016, 101, 3487–3496. [Google Scholar] [CrossRef] [Green Version]
- Md Moin, A.S.; Cory, M.; Ong, A.; Choi, J.; Dhawan, S.; Butler, P.C.; Butler, A.E. Pancreatic Nonhormone Expressing Endocrine Cells in Children With Type 1 Diabetes. J. Endocr. Soc. 2017, 1, 385–395. [Google Scholar] [CrossRef] [Green Version]
- Van Hulle, F.; De Groot, K.; Hilbrands, R.; Van de Velde, U.; Suenens, K.; Stangé, G.; De Mesmaeker, I.; De Paep, D.L.; Ling, Z.; Roep, B.; et al. Function and composition of pancreatic islet cell implants in omentum of type 1 diabetes patients. Am. J. Transplant. 2022, 22, 927–936. [Google Scholar] [CrossRef]
- Jonsson, J.; Carlsson, L.; Edlund, T.; Edlund, H. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 1994, 371, 606–609. [Google Scholar] [CrossRef]
- Offield, M.F.; Jetton, T.L.; Labosky, P.A.; Ray, M.; Stein, R.W.; Magnuson, M.A.; Hogan, B.L.; Wright, C.V. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 1996, 122, 983–995. [Google Scholar] [CrossRef]
- Krapp, A.; Knöfler, M.; Frutiger, S.; Hughes, G.J.; Hagenbüchle, O.; Wellauer, P.K. The p48 DNA-binding subunit of transcription factor PTF1 is a new exocrine pancreas-specific basic helix-loop-helix protein. EMBO J. 1996, 15, 4317–4329. [Google Scholar]
- Hald, J.; Sprinkel, A.E.; Ray, M.; Serup, P.; Wright, C.; Madsen, O.D. Generation and characterization of Ptf1a antiserum and localization of Ptf1a in relation to Nkx6.1 and Pdx1 during the earliest stages of mouse pancreas development. J. Histochem. Cytochem. 2008, 56, 587–595. [Google Scholar] [CrossRef] [Green Version]
- Schisler, J.C.; Jensen, P.B.; Taylor, D.G.; Becker, T.C.; Knop, F.K.; Takekawa, S.; German, M.; Weir, G.C.; Lu, D.; Mirmira, R.G.; et al. The Nkx6.1 homeodomain transcription factor suppresses glucagon expression and regulates glucose-stimulated insulin secretion in islet beta cells. Proc. Natl. Acad. Sci. USA 2005, 102, 7297–7302. [Google Scholar] [CrossRef] [Green Version]
- Schisler, J.C.; Fueger, P.T.; Babu, D.A.; Hohmeier, H.E.; Tessem, J.S.; Lu, D.; Becker, T.C.; Naziruddin, B.; Levy, M.; Mirmira, R.G.; et al. Stimulation of human and rat islet beta-cell proliferation with retention of function by the homeodomain transcription factor Nkx6.1. Mol. Cell. Biol. 2008, 28, 3465–3476. [Google Scholar] [CrossRef] [Green Version]
- Kawaguchi, Y.; Cooper, B.; Gannon, M.; Ray, M.; MacDonald, R.J.; Wright, C.V. The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors. Nat. Genet. 2002, 32, 128–134. [Google Scholar] [CrossRef]
- Schaffer, A.E.; Freude, K.K.; Nelson, S.B.; Sander, M. Nkx6 transcription factors and Ptf1a function as antagonistic lineage determinants in multipotent pancreatic progenitors. Dev. Cell 2010, 18, 1022–1029. [Google Scholar] [CrossRef] [Green Version]
- Gu, G.; Dubauskaite, J.; Melton, D.A. Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development 2002, 129, 2447–2457. [Google Scholar] [CrossRef]
- Gradwohl, G.; Dierich, A.; LeMeur, M.; Guillemot, F. neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc. Natl. Acad. Sci. USA 2000, 97, 1607–1611. [Google Scholar] [CrossRef] [Green Version]
- Sussel, L.; Kalamaras, J.; Hartigan-O’Connor, D.J.; Meneses, J.J.; Pedersen, R.A.; Rubenstein, J.L.; German, M.S. Mice lacking the homeodomain transcription factor Nkx2.2 have diabetes due to arrested differentiation of pancreatic beta cells. Development 1998, 125, 2213–2221. [Google Scholar] [CrossRef]
- Prado, C.L.; Pugh-Bernard, A.E.; Elghazi, L.; Sosa-Pineda, B.; Sussel, L. Ghrelin cells replace insulin-producing beta cells in two mouse models of pancreas development. Proc. Natl. Acad. Sci. USA 2004, 101, 2924–2929. [Google Scholar] [CrossRef] [Green Version]
- Sosa-Pineda, B.; Chowdhury, K.; Torres, M.; Oliver, G.; Gruss, P. The Pax4 gene is essential for differentiation of insulin-producing beta cells in the mammalian pancreas. Nature 1997, 386, 399–402. [Google Scholar] [CrossRef]
- Collombat, P.; Mansouri, A.; Hecksher-Sorensen, J.; Serup, P.; Krull, J.; Gradwohl, G.; Gruss, P. Opposing actions of Arx and Pax4 in endocrine pancreas development. Genes Dev. 2003, 17, 2591–2603. [Google Scholar] [CrossRef] [Green Version]
- Collombat, P.; Hecksher-Sorensen, J.; Broccoli, V.; Krull, J.; Ponte, I.; Mundiger, T.; Smith, J.; Gruss, P.; Serup, P.; Mansouri, A. The simultaneous loss of Arx and Pax4 genes promotes a somatostatin-producing cell fate specification at the expense of the alpha- and beta-cell lineages in the mouse endocrine pancreas. Development 2005, 132, 2969–2980. [Google Scholar] [CrossRef] [Green Version]
- Collombat, P.; Hecksher-Sørensen, J.; Krull, J.; Berger, J.; Riedel, D.; Herrera, P.L.; Serup, P.; Mansouri, A. Embryonic endocrine pancreas and mature beta cells acquire alpha and PP cell phenotypes upon Arx misexpression. J. Clin. Investig. 2007, 117, 961–970. [Google Scholar] [CrossRef] [Green Version]
- Schaffer, A.E.; Taylor, B.L.; Benthuysen, J.R.; Liu, J.; Thorel, F.; Yuan, W.; Jiao, Y.; Kaestner, K.H.; Herrera, P.L.; Magnuson, M.A.; et al. Nkx6.1 controls a gene regulatory network required for establishing and maintaining pancreatic Beta cell identity. PLoS Genet. 2013, 9, e1003274. [Google Scholar] [CrossRef] [Green Version]
- Taylor, B.L.; Liu, F.F.; Sander, M. Nkx6.1 is essential for maintaining the functional state of pancreatic beta cells. Cell Rep. 2013, 4, 1262–1275. [Google Scholar] [CrossRef] [Green Version]
- Papizan, J.B.; Singer, R.A.; Tschen, S.I.; Dhawan, S.; Friel, J.M.; Hipkens, S.B.; Magnuson, M.A.; Bhushan, A.; Sussel, L. Nkx2.2 repressor complex regulates islet β-cell specification and prevents β-to-α-cell reprogramming. Genes Dev. 2011, 25, 2291–2305. [Google Scholar] [CrossRef] [Green Version]
- Herrera, P.L. Adult insulin- and glucagon-producing cells differentiate from two independent cell lineages. Development 2000, 127, 2317–2322. [Google Scholar] [CrossRef]
- Lee, K.; Chan, J.Y.; Liang, C.; Ip, C.K.; Shi, Y.C.; Herzog, H.; Hughes, W.E.; Bensellam, M.; Delghingaro-Augusto, V.; Koina, M.E.; et al. XBP1 maintains beta cell identity, represses beta-to-alpha cell transdifferentiation and protects against diabetic beta cell failure during metabolic stress in mice. Diabetologia 2022, 65, 984–996. [Google Scholar] [CrossRef]
- Spijker, H.S.; Ravelli, R.B.; Mommaas-Kienhuis, A.M.; van Apeldoorn, A.A.; Engelse, M.A.; Zaldumbide, A.; Bonner-Weir, S.; Rabelink, T.J.; Hoeben, R.C.; Clevers, H.; et al. Conversion of mature human β-cells into glucagon-producing α-cells. Diabetes 2013, 62, 2471–2480. [Google Scholar] [CrossRef] [Green Version]
- Butler, A.E.; Campbell-Thompson, M.; Gurlo, T.; Dawson, D.W.; Atkinson, M.; Butler, P.C. Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors. Diabetes 2013, 62, 2595–2604. [Google Scholar] [CrossRef] [Green Version]
- Spijker, H.S.; Song, H.; Ellenbroek, J.H.; Roefs, M.M.; Engelse, M.A.; Bos, E.; Koster, A.J.; Rabelink, T.J.; Hansen, B.C.; Clark, A.; et al. Loss of β-Cell Identity Occurs in Type 2 Diabetes and Is Associated With Islet Amyloid Deposits. Diabetes 2015, 64, 2928–2938. [Google Scholar] [CrossRef] [Green Version]
- Pipeleers, D. The biosociology of pancreatic B cells. Diabetologia 1987, 30, 277–291. [Google Scholar] [CrossRef] [Green Version]
- Pipeleers, D.G. Heterogeneity in pancreatic beta-cell population. Diabetes 1992, 41, 777–781. [Google Scholar] [CrossRef]
- Pipeleers, D.; Kiekens, R.; Ling, Z.; Wilikens, A.; Schuit, F. Physiologic relevance of heterogeneity in the pancreatic beta-cell population. Diabetologia 1994, 37 (Suppl. S2), S57–S64. [Google Scholar] [CrossRef]
- Bader, E.; Migliorini, A.; Gegg, M.; Moruzzi, N.; Gerdes, J.; Roscioni, S.S.; Bakhti, M.; Brandl, E.; Irmler, M.; Beckers, J.; et al. Identification of proliferative and mature beta-cells in the islets of Langerhans. Nature 2016, 535, 430–434. [Google Scholar] [CrossRef]
- van der Meulen, T.; Mawla, A.M.; DiGruccio, M.R.; Adams, M.W.; Nies, V.; Dolleman, S.; Liu, S.; Ackermann, A.M.; Caceres, E.; Hunter, A.E.; et al. Virgin Beta Cells Persist throughout Life at a Neogenic Niche within Pancreatic Islets. Cell Metab. 2017, 25, 911–926.e916. [Google Scholar] [CrossRef] [Green Version]
- Bosco, D.; Rouiller, D.G.; Halban, P.A. Differential expression of E-cadherin at the surface of rat beta-cells as a marker of functional heterogeneity. J. Endocrinol. 2007, 194, 21–29. [Google Scholar] [CrossRef] [Green Version]
- Segerstolpe, A.; Palasantza, A.; Eliasson, P.; Andersson, E.M.; Andreasson, A.C.; Sun, X.; Picelli, S.; Sabirsh, A.; Clausen, M.; Bjursell, M.K.; et al. Single-Cell Transcriptome Profiling of Human Pancreatic Islets in Health and Type 2 Diabetes. Cell Metab. 2016, 24, 593–607. [Google Scholar] [CrossRef] [Green Version]
- Xin, Y.; Dominguez Gutierrez, G.; Okamoto, H.; Kim, J.; Lee, A.H.; Adler, C.; Ni, M.; Yancopoulos, G.D.; Murphy, A.J.; Gromada, J. Pseudotime Ordering of Single Human β-Cells Reveals States of Insulin Production and Unfolded Protein Response. Diabetes 2018, 67, 1783–1794. [Google Scholar] [CrossRef] [Green Version]
- Dorrell, C.; Schug, J.; Canaday, P.S.; Russ, H.A.; Tarlow, B.D.; Grompe, M.T.; Horton, T.; Hebrok, M.; Streeter, P.R.; Kaestner, K.H.; et al. Human islets contain four distinct subtypes of beta cells. Nat. Commun. 2016, 7, 11756. [Google Scholar] [CrossRef] [Green Version]
- Wojtusciszyn, A.; Armanet, M.; Morel, P.; Berney, T.; Bosco, D. Insulin secretion from human beta cells is heterogeneous and dependent on cell-to-cell contacts. Diabetologia 2008, 51, 1843–1852. [Google Scholar] [CrossRef] [Green Version]
- Hiriart, M.; Ramirez-Medeles, M.C. Functional subpopulations of individual pancreatic B-cells in culture. Endocrinology 1991, 128, 3193–3198. [Google Scholar] [CrossRef]
- Salem, V.; Silva, L.D.; Suba, K.; Georgiadou, E.; Neda Mousavy Gharavy, S.; Akhtar, N.; Martin-Alonso, A.; Gaboriau, D.C.A.; Rothery, S.M.; Stylianides, T.; et al. Leader β-cells coordinate Ca. Nat. Metab. 2019, 1, 615–629. [Google Scholar] [CrossRef] [Green Version]
- Nunemaker, C.S.; Wasserman, D.H.; McGuinness, O.P.; Sweet, I.R.; Teague, J.C.; Satin, L.S. Insulin secretion in the conscious mouse is biphasic and pulsatile. Am. J. Physiol. Endocrinol. Metab. 2006, 290, E523–E529. [Google Scholar] [CrossRef]
- Gilon, P.; Ravier, M.A.; Jonas, J.C.; Henquin, J.C. Control mechanisms of the oscillations of insulin secretion in vitro and in vivo. Diabetes 2002, 51 (Suppl. S1), S144–S151. [Google Scholar] [CrossRef] [Green Version]
- Matveyenko, A.V.; Liuwantara, D.; Gurlo, T.; Kirakossian, D.; Dalla Man, C.; Cobelli, C.; White, M.F.; Copps, K.D.; Volpi, E.; Fujita, S.; et al. Pulsatile portal vein insulin delivery enhances hepatic insulin action and signaling. Diabetes 2012, 61, 2269–2279. [Google Scholar] [CrossRef] [Green Version]
- Johnston, N.R.; Mitchell, R.K.; Haythorne, E.; Pessoa, M.P.; Semplici, F.; Ferrer, J.; Piemonti, L.; Marchetti, P.; Bugliani, M.; Bosco, D.; et al. Beta Cell Hubs Dictate Pancreatic Islet Responses to Glucose. Cell Metab. 2016, 24, 389–401. [Google Scholar] [CrossRef] [Green Version]
- Thompson, P.J.; Shah, A.; Ntranos, V.; Van Gool, F.; Atkinson, M.; Bhushan, A. Targeted Elimination of Senescent Beta Cells Prevents Type 1 Diabetes. Cell Metab. 2019, 29, 1045–1060.e10. [Google Scholar] [CrossRef]
- Rodier, F.; Coppé, J.P.; Patil, C.K.; Hoeijmakers, W.A.; Muñoz, D.P.; Raza, S.R.; Freund, A.; Campeau, E.; Davalos, A.R.; Campisi, J. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat. Cell Biol. 2009, 11, 973–979. [Google Scholar] [CrossRef]
- Tchkonia, T.; Zhu, Y.; van Deursen, J.; Campisi, J.; Kirkland, J.L. Cellular senescence and the senescent secretory phenotype: Therapeutic opportunities. J. Clin. Investig. 2013, 123, 966–972. [Google Scholar] [CrossRef] [Green Version]
- Kirkland, J.L.; Tchkonia, T. Cellular Senescence: A Translational Perspective. EBioMedicine 2017, 21, 21–28. [Google Scholar] [CrossRef] [Green Version]
- Aguayo-Mazzucato, C.; Andle, J.; Lee, T.B., Jr.; Midha, A.; Talemal, L.; Chipashvili, V.; Hollister-Lock, J.; van Deursen, J.; Weir, G.; Bonner-Weir, S. Acceleration of beta Cell Aging Determines Diabetes and Senolysis Improves Disease Outcomes. Cell Metab. 2019, 30, 129–142.e124. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Shilleh, A.H.; Russ, H.A. Cell Replacement Therapy for Type 1 Diabetes Patients: Potential Mechanisms Leading to Stem-Cell-Derived Pancreatic β-Cell Loss upon Transplant. Cells 2023, 12, 698. https://doi.org/10.3390/cells12050698
Shilleh AH, Russ HA. Cell Replacement Therapy for Type 1 Diabetes Patients: Potential Mechanisms Leading to Stem-Cell-Derived Pancreatic β-Cell Loss upon Transplant. Cells. 2023; 12(5):698. https://doi.org/10.3390/cells12050698
Chicago/Turabian StyleShilleh, Ali H., and Holger A. Russ. 2023. "Cell Replacement Therapy for Type 1 Diabetes Patients: Potential Mechanisms Leading to Stem-Cell-Derived Pancreatic β-Cell Loss upon Transplant" Cells 12, no. 5: 698. https://doi.org/10.3390/cells12050698
APA StyleShilleh, A. H., & Russ, H. A. (2023). Cell Replacement Therapy for Type 1 Diabetes Patients: Potential Mechanisms Leading to Stem-Cell-Derived Pancreatic β-Cell Loss upon Transplant. Cells, 12(5), 698. https://doi.org/10.3390/cells12050698